Asian Health Services / GlaxoSmithKline / Schering-Plough / Bristol-Myers Squibb / All About / Alteon Inc. / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
Facility
Stanford University / /
IndustryTerm
pharmaceutical industry / telephone menu options / food / insurance coverage / pharmaceutical research / disease management / HBV Treatment / treatment for HIV / online publication / Hepatitis Prevention / /
MedicalCondition
hepatitis A / HIV / HBV / active infection / breakthrough infection / Cirrhosis / hepatitis C / hepatitis B / hepatitis / Thereby Avoid/Reverse Fibrosis / liver disease / HBV Genotype / Necrosis / cancer / disease / very serious hepatitis / To Significantly Reduce Liver Inflammation / liver diseases / HCV / viral infections / kidney failure / liver cancer / resistant hepatitis B / histologically active disease / HIV/AIDS / infection / viral hepatitis / chronic hepatitis B / /
MedicalTreatment
immunization / antiviral therapy / /
Organization
Division of Disease Prevention / Asian Liver Center / Immunization Action Coalition / Pacific Islander Health Forum / Clinical Trials Listing Service / Stanford University / FDA / Viral Hepatitis Prevention Board / American Liver Foundation / / /
Position
leader in pharmaceutical research / /
Product
Hepsera / Epivir-HBV / Lamivudine / Intron A / Baraclude / Hepsera® / not stop taking Hepsera / /
Microsoft Word - HBV and HCV Website Referral, Treatment Explanation, and Patient AssistancePrograms..doc